Links
Organizations
Conferences
Info & Opinion
March 13, 2010
ClinPage Exclusive: Jerry Schindler
The Biostatistical Case For EDC
A discussion about infrastructure for adaptive clinical trials. With process change and the right technology, Cytel‘s Jerry Schindler says, pharma could wring significant savings out of clinical development.
- Home
- Tag
- adaptive
It is utterly impossible to pigeonhole Dr. Jerald Schindler. We’ve tried. Schindler confounds the three easiest caricatures that any self-respecting journalist would reach for. Schindler is a biostatistician, but speaks fluidly, lucidly. He’s a vendor, but leaves his Cytel sales pitch…
No articles available
